164 related articles for article (PubMed ID: 31144474)
1. Promyelocytic leukemia protein deficiency leads to spontaneous formation of liver tumors in hepatitis C virus transgenic mice.
Straub K; Husen P; Baba HA; Trippler M; Wedemeyer H; Herzer K
Cancer Med; 2019 Jul; 8(8):3793-3802. PubMed ID: 31144474
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of the promyelocytic leukemia protein fosters hepatitis C-associated hepatocarcinogenesis in mice.
Herzer K; Carbow A; Sydor S; Sowa JP; Biesterfeld S; Hofmann TG; Galle PR; Gerken G; Canbay A
PLoS One; 2012; 7(9):e44474. PubMed ID: 22984515
[TBL] [Abstract][Full Text] [Related]
3. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
4. Dual oncogenic and tumor suppressor roles of the promyelocytic leukemia gene in hepatocarcinogenesis associated with hepatitis B virus surface antigen.
Chung YL; Wu ML
Oncotarget; 2016 May; 7(19):28393-407. PubMed ID: 27058621
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C-associated liver carcinogenesis: role of PML nuclear bodies.
Herzer K; Gerken G; Hofmann TG
World J Gastroenterol; 2014 Sep; 20(35):12367-71. PubMed ID: 25253937
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies.
Koike K
Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S132-5. PubMed ID: 16234061
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of promyelocytic leukemia protein and alteration of PML nuclear bodies in early stage of hepatocarcinogenesis.
Yoon GS; Yu E
J Korean Med Sci; 2001 Aug; 16(4):433-8. PubMed ID: 11511788
[TBL] [Abstract][Full Text] [Related]
9. The oncogenic role of hepatitis C virus.
Koike K
Recent Results Cancer Res; 2014; 193():97-111. PubMed ID: 24008295
[TBL] [Abstract][Full Text] [Related]
10. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
Tabor E
Princess Takamatsu Symp; 1995; 25():151-61. PubMed ID: 8875620
[TBL] [Abstract][Full Text] [Related]
11. Bicluster and pathway enrichment analysis of HCV-induced cirrhosis and hepatocellular carcinoma.
Cheng P; Cheng Y; Su MX; Li D; Zhao GZ; Gao H; Li Y; Zhu JY; Li H; Zhang T
Asian Pac J Cancer Prev; 2012; 13(8):3741-5. PubMed ID: 23098464
[TBL] [Abstract][Full Text] [Related]
12. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
13. Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.
Fujinaga H; Tsutsumi T; Yotsuyanagi H; Moriya K; Koike K
Oncology; 2011; 81 Suppl 1():11-7. PubMed ID: 22212930
[TBL] [Abstract][Full Text] [Related]
14. Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma.
Plissonnier ML; Herzog K; Levrero M; Zeisel MB
Viruses; 2018 Oct; 10(11):. PubMed ID: 30380697
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues.
Chan JY; Chin W; Liew CT; Chang KS; Johnson PJ
Eur J Cancer; 1998 Jun; 34(7):1015-22. PubMed ID: 9849449
[TBL] [Abstract][Full Text] [Related]
16. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
[TBL] [Abstract][Full Text] [Related]
17. Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53.
Duong FH; Dill MT; Matter MS; Makowska Z; Calabrese D; Dietsche T; Ketterer S; Terracciano L; Heim MH
Carcinogenesis; 2014 Jan; 35(1):114-22. PubMed ID: 23901063
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
19. Concordant expression of proto-oncogene promyelocytic leukemia and major histocompatibility antigen HLA class I in human hepatocellular carcinoma.
Xia M; Zhang JQ; Shen YQ; Xu LH; Chen AQ; Miao FQ; Xie W
Tissue Antigens; 2007 Oct; 70(4):272-82. PubMed ID: 17767548
[TBL] [Abstract][Full Text] [Related]
20. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
